nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Esmolol—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Esmolol—Inflammation—Methotrexate—psoriatic arthritis	0.00444	0.00444	CcSEcCtD
Esmolol—Cardiac failure—Dexamethasone—psoriatic arthritis	0.0044	0.0044	CcSEcCtD
Esmolol—Cardiac failure—Betamethasone—psoriatic arthritis	0.0044	0.0044	CcSEcCtD
Esmolol—Respiratory failure—Methotrexate—psoriatic arthritis	0.00439	0.00439	CcSEcCtD
Esmolol—Sweating increased—Prednisolone—psoriatic arthritis	0.00433	0.00433	CcSEcCtD
Esmolol—Thrombophlebitis—Prednisone—psoriatic arthritis	0.00432	0.00432	CcSEcCtD
Esmolol—Cardiac failure congestive—Prednisone—psoriatic arthritis	0.00412	0.00412	CcSEcCtD
Esmolol—Skin exfoliation—Methotrexate—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Esmolol—Irritability—Dexamethasone—psoriatic arthritis	0.0041	0.0041	CcSEcCtD
Esmolol—Irritability—Betamethasone—psoriatic arthritis	0.0041	0.0041	CcSEcCtD
Esmolol—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00408	0.00408	CcSEcCtD
Esmolol—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00408	0.00408	CcSEcCtD
Esmolol—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.00402	0.00402	CcSEcCtD
Esmolol—Sweating increased—Triamcinolone—psoriatic arthritis	0.00399	0.00399	CcSEcCtD
Esmolol—Sweating increased—Methylprednisolone—psoriatic arthritis	0.00398	0.00398	CcSEcCtD
Esmolol—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.00391	0.00391	CcSEcCtD
Esmolol—Ecchymosis—Methotrexate—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Esmolol—Myocardial infarction—Prednisolone—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Esmolol—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Esmolol—Pulmonary oedema—Methotrexate—psoriatic arthritis	0.00383	0.00383	CcSEcCtD
Esmolol—Cardiac failure—Prednisone—psoriatic arthritis	0.00383	0.00383	CcSEcCtD
Esmolol—Bradycardia—Prednisolone—psoriatic arthritis	0.00363	0.00363	CcSEcCtD
Esmolol—Sweating increased—Dexamethasone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Esmolol—Sweating increased—Betamethasone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Esmolol—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Esmolol—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Esmolol—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Esmolol—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Esmolol—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Esmolol—Irritability—Prednisone—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Esmolol—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Esmolol—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Esmolol—Cardiac arrest—Prednisone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Esmolol—Visual impairment—Prednisolone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Esmolol—Bradycardia—Triamcinolone—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Esmolol—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Esmolol—Rhinitis—Triamcinolone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Esmolol—Rhinitis—Methylprednisolone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Esmolol—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Esmolol—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Esmolol—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Esmolol—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Esmolol—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Esmolol—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Esmolol—Myocardial infarction—Betamethasone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Esmolol—Sweating increased—Prednisone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Esmolol—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Esmolol—Erythema—Prednisolone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Esmolol—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Esmolol—Bradycardia—Dexamethasone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Esmolol—Bradycardia—Betamethasone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Esmolol—Irritability—Methotrexate—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Esmolol—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Esmolol—Visual impairment—Betamethasone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Esmolol—Visual impairment—Dexamethasone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Esmolol—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Esmolol—Erythema—Triamcinolone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Esmolol—Erythema—Methylprednisolone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Esmolol—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Esmolol—Angioedema—Prednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Esmolol—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Esmolol—Myocardial infarction—Prednisone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Esmolol—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Esmolol—Syncope—Prednisolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Esmolol—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Esmolol—Angiopathy—Betamethasone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Esmolol—Angiopathy—Dexamethasone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Esmolol—Convulsion—Prednisolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Esmolol—Bradycardia—Prednisone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Esmolol—Angioedema—Triamcinolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Esmolol—Angioedema—Methylprednisolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Esmolol—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Esmolol—Erythema—Betamethasone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Esmolol—Erythema—Dexamethasone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Esmolol—Syncope—Triamcinolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Esmolol—Syncope—Methylprednisolone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Esmolol—Oedema—Prednisolone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Esmolol—Dysuria—Methotrexate—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Esmolol—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Esmolol—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Esmolol—Shock—Prednisolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Esmolol—Convulsion—Triamcinolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Esmolol—Convulsion—Methylprednisolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Esmolol—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Esmolol—Anxiety—Methylprednisolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Esmolol—Drowsiness—Methotrexate—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Esmolol—Flushing—Prednisone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Esmolol—Dry mouth—Triamcinolone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Esmolol—Angioedema—Dexamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Esmolol—Angioedema—Betamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Esmolol—Angiopathy—Prednisone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Esmolol—Confusional state—Methylprednisolone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Esmolol—Oedema—Triamcinolone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Esmolol—Syncope—Dexamethasone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Esmolol—Syncope—Betamethasone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Esmolol—Shock—Triamcinolone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Esmolol—Shock—Methylprednisolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Esmolol—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Esmolol—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Esmolol—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Esmolol—Paraesthesia—Prednisolone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Esmolol—Mental disorder—Prednisone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Esmolol—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Esmolol—Erythema—Prednisone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Esmolol—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Esmolol—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Esmolol—Convulsion—Dexamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Esmolol—Convulsion—Betamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Esmolol—Anxiety—Dexamethasone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Esmolol—Anxiety—Betamethasone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Esmolol—Hypotension—Methylprednisolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Esmolol—Pain—Prednisolone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Esmolol—Pharyngitis—Methotrexate—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Esmolol—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Esmolol—Urethral disorder—Methotrexate—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Esmolol—Oedema—Betamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Esmolol—Oedema—Dexamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Esmolol—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Esmolol—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Esmolol—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Esmolol—Visual impairment—Methotrexate—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Esmolol—Shock—Dexamethasone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Esmolol—Shock—Betamethasone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Esmolol—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Esmolol—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Esmolol—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Esmolol—Agitation—Prednisone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Esmolol—Angioedema—Prednisone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Esmolol—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Esmolol—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Esmolol—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Esmolol—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Esmolol—Syncope—Prednisone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Esmolol—Anorexia—Dexamethasone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Esmolol—Anorexia—Betamethasone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Esmolol—Urticaria—Prednisolone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Esmolol—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Esmolol—Fatigue—Triamcinolone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Esmolol—Fatigue—Methylprednisolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Esmolol—Pain—Triamcinolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Esmolol—Loss of consciousness—Prednisone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Esmolol—Hypotension—Dexamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Esmolol—Hypotension—Betamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Esmolol—Angiopathy—Methotrexate—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Esmolol—Convulsion—Prednisone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Esmolol—Chills—Methotrexate—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Esmolol—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Esmolol—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Esmolol—Anxiety—Prednisone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Esmolol—Paraesthesia—Betamethasone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Esmolol—Paraesthesia—Dexamethasone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Esmolol—Mental disorder—Methotrexate—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Esmolol—Erythema—Methotrexate—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Esmolol—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Esmolol—Dyspepsia—Betamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Esmolol—Urticaria—Triamcinolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Esmolol—Urticaria—Methylprednisolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Esmolol—Dysgeusia—Methotrexate—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Esmolol—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Esmolol—Oedema—Prednisone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Esmolol—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Esmolol—Decreased appetite—Betamethasone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Esmolol—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Esmolol—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Esmolol—Fatigue—Dexamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Esmolol—Fatigue—Betamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Esmolol—Shock—Prednisone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Esmolol—Pain—Betamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Esmolol—Pain—Dexamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Esmolol—Nervous system disorder—Prednisone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Esmolol—Skin disorder—Prednisone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Esmolol—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Esmolol—Anorexia—Prednisone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Esmolol—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Esmolol—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Esmolol—Urticaria—Dexamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Esmolol—Urticaria—Betamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Esmolol—Dizziness—Prednisolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Esmolol—Asthenia—Triamcinolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Esmolol—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Esmolol—Body temperature increased—Betamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Esmolol—Asthenia—Methylprednisolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Esmolol—Paraesthesia—Prednisone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Esmolol—Pruritus—Triamcinolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Esmolol—Pruritus—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Esmolol—Convulsion—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Esmolol—Dyspepsia—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Esmolol—Chest pain—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Esmolol—Decreased appetite—Prednisone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Esmolol—Fatigue—Prednisone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Esmolol—Headache—Prednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Esmolol—Constipation—Prednisone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Esmolol—Confusional state—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Esmolol—Dizziness—Triamcinolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Esmolol—Dizziness—Methylprednisolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Esmolol—Feeling abnormal—Prednisone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Esmolol—Asthenia—Dexamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Esmolol—Asthenia—Betamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Esmolol—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Esmolol—Nausea—Prednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Esmolol—Pruritus—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Esmolol—Pruritus—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Esmolol—Skin disorder—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Esmolol—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Esmolol—Vomiting—Triamcinolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Esmolol—Vomiting—Methylprednisolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Esmolol—Anorexia—Methotrexate—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Esmolol—Urticaria—Prednisone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Esmolol—Headache—Triamcinolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Esmolol—Headache—Methylprednisolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Esmolol—Body temperature increased—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Esmolol—Hypotension—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Esmolol—Dizziness—Betamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Esmolol—Dizziness—Dexamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Esmolol—Nausea—Triamcinolone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Esmolol—Paraesthesia—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Esmolol—Nausea—Methylprednisolone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Esmolol—Dyspnoea—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Esmolol—Somnolence—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Esmolol—Dyspepsia—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Esmolol—Vomiting—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Esmolol—Vomiting—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Esmolol—Decreased appetite—Methotrexate—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Esmolol—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Esmolol—Fatigue—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Esmolol—Headache—Betamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Esmolol—Headache—Dexamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Esmolol—Asthenia—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Esmolol—Pain—Methotrexate—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Esmolol—Pruritus—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Esmolol—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Esmolol—Nausea—Betamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Esmolol—Nausea—Dexamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Esmolol—Urticaria—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Esmolol—Dizziness—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Esmolol—Body temperature increased—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Esmolol—Vomiting—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Esmolol—Headache—Prednisone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Esmolol—Asthenia—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Esmolol—Nausea—Prednisone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Esmolol—Pruritus—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Esmolol—Dizziness—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Esmolol—Vomiting—Methotrexate—psoriatic arthritis	0.000977	0.000977	CcSEcCtD
Esmolol—Headache—Methotrexate—psoriatic arthritis	0.000962	0.000962	CcSEcCtD
Esmolol—Nausea—Methotrexate—psoriatic arthritis	0.000913	0.000913	CcSEcCtD
